Convergence Investment Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,428
| Closed | -$1.29M | – | 259 |
|
|
2025
Q1 | $1.29M | Buy |
10,428
+2,043
| +24% | +$254K | 0.36% | 93 |
|
|
2024
Q4 | $1.03M | Buy |
+8,385
| New | +$1.03M | 0.23% | 143 |
|
|
2024
Q1 | – | Sell |
-1,800
| Closed | -$221K | – | 256 |
|
|
2023
Q4 | $221K | Buy |
1,800
+72
| +4% | +$8.84K | 0.12% | 178 |
|
|
2023
Q3 | $224K | Buy |
+1,728
| New | +$224K | 0.13% | 140 |
|
|
2016
Q3 | – | Sell |
-13,615
| Closed | -$1.92M | – | 358 |
|
|
2016
Q2 | $1.92M | Sell |
13,615
-638
| -4% | -$90.2K | 0.26% | 139 |
|
|
2016
Q1 | $1.86M | Buy |
14,253
+4,564
| +47% | +$596K | 0.22% | 159 |
|
|
2015
Q4 | $1.36M | Sell |
9,689
-1,670
| -15% | -$235K | 0.15% | 211 |
|
|
2015
Q3 | $1.51M | Buy |
+11,359
| New | +$1.51M | 0.17% | 190 |
|